Warning: Undefined array key "network" in /hshare1/ZETTAI_path_WA_slash_usr_slash_proj_KARA/usr/proj/tcng/htdocs/tcng.php on line 565

Edge

KPNA1 → HMGCS1

GSE10445_egf1520 - GSE10445 - SiGN-BN HC+Bootstrap	MERLION LUNG CANCER STUDY
GSE10810_egf1520 - GSE10810 - SiGN-BN HC+Bootstrap	Gene expression signatures in breast cancer distinguish phenotype charact., histological subtypes, and tumor invasivness
GSE12276_egf1520 - GSE12276 - SiGN-BN HC+Bootstrap	Expression data from primary breast tumors
GSE16237_egf1520 - GSE16237 - SiGN-BN HC+Bootstrap	Expression data of human neuroblastoma tissue samples
GSE16382_egf1520 - GSE16382 - SiGN-BN HC+Bootstrap	Expression data from complex genetic sarcomas
GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap	Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial
GSE18842_egf1520 - GSE18842 - SiGN-BN HC+Bootstrap	Gene expression analysis of human lung cancer and control samples
GSE19188_egf1520 - GSE19188 - SiGN-BN HC+Bootstrap	Expression data for early stage NSCLC
GSE23980_egf1520 - GSE23980 - SiGN-BN HC+Bootstrap	Expression data from human soft tissue sarcomas with complex genomics
GSE4290_egf1520 - GSE4290 - SiGN-BN HC+Bootstrap	Expression data of glioma samples from Henry Ford Hospital
GSE4581_egf1520 - GSE4581 - SiGN-BN HC+Bootstrap	Gene Expression Profiles of Multiple Myeloma (N=414) Before Treatment
GSE6008_egf1520 - GSE6008 - SiGN-BN HC+Bootstrap	Human ovarian tumors and normal ovaries
GSE8894_egf1520 - GSE8894 - SiGN-BN HC+Bootstrap	Prediction of Recurrence-Free Survival in Postoperative NSCLC Patients—a Useful Prospective Clinical Practice